Generation of Cytotoxic Factor by Human Large Granular Lymphocytes During Interaction With Autologous Tumor Cells: Lysis of Fresh Human Tumor Cells
- 1 November 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 80 (17) , 1398-1403
- https://doi.org/10.1093/jnci/80.17.1398
Abstract
Large granular lymphicytes (LGL) obtained by centrifugation (Percoll gradient) of blood from patients with carcinomatous pleural effusions and solid tumors lysed autologous, freshly isolated tumor cells in a 4-hour 5 Cr-release assy. When cocultured with autologous tumor Cells, LGL released souble cytotoxic factor(s), large granular lymphocyte-derived cytotoxic factor (LGL-CF). In contrast, small T lymphocytes were unable to kill autologous tumor cells or to produce a cytotoxic factor. The LGL-CF demonstrated cytotoxcity against autologous fresh tumor cells but also against allogeneic fresh tumor cells in a 48-hour microcytotoxicity assay and in an 18-hour 5Cr-release assay in the presence of dactionomycin. Binding of LGL-CF to autologous tumor cells occurred within 2 hours and reached the maximum by 6 hours; this binding was sufficient to cause subsequent lysis of the target cells without the continued presence of LGL-CF. Neither the supernatants produced by culture of LGL alone nor the lysates of LGL-CF. had detectable cytolytic activity. In addition, treatment of LGL with cytochalasin A inhibited both direct cell-mediated autologous tumor lysis and generation of LGL-CF. Production of LGL-CF required active cell metabolism and protein and RNA syntheses in LGL, but not DNA synthesis. Addition of dactinomycin to LGL-CF in assays augmented the lysis. LGL-GF was stable at 56° but it was reduced at 70 ° and destroyed at 100 ° Treatment of LGL-GF with trypsin or proteinase K reduced or abrogated the lytic effect, respectively, while the lytic effect was not affected by papain, catalase, or superoxide dismutase. These results indicate that during interaction with autologous tumor cells, LGL release a soluble cytotoxic factor that mediates lysis of fresh human tumor cells. [J Natl Cancer Inst 1988:80:1398–14030]Keywords
This publication has 11 references indexed in Scilit:
- Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.The Journal of Immunology, 1986
- Lysis of autologous tumor cells by high‐density lymphocytes is potentiated by the streptococcal preparation OK432 (picibanil)International Journal of Cancer, 1986
- Suppression of T-cell Response in Autologous Mixed Lymphocyte-Tumor Culture by Large Granular Lymphocytes2JNCI Journal of the National Cancer Institute, 1986
- Natural Cytotoxicity of Human Blood Lymphocytes and Monocytes and Their Cytotoxic Factors: Effect of Interferon on Target Cell Susceptibility2JNCI Journal of the National Cancer Institute, 1985
- Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: Discriminating effects of actinomycin DInternational Journal of Cancer, 1985
- Lysis of Fresh Human Tumor Cells by Autologous Large Granular Lymphocytes and T-Lymphocytes: Two Distinct Killing Activities Induced by Coculture With Autologous Tumor2JNCI Journal of the National Cancer Institute, 1984
- Natural Killer Cell Activity and Autologous Tumor Killing Activity in Cancer Patients: Overlapping Involvement of Effector Cells as Determined in Two-Target Conjugate Cytotoxicity Assay2JNCI Journal of the National Cancer Institute, 1984
- Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusionsInternational Journal of Cancer, 1983
- Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.The Journal of Immunology, 1982
- Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.The Journal of Immunology, 1980